Cannabinoids and the endocannabinoid system in liver diseases

被引：0
作者：
Parfieniuk-Kowerda, Anna [1 ]
Martonik, Diana [1 ]
Andrzejuk, Aleksandra [2 ]
Tarasik, Aleksander [3 ]
Flisiak, Robert [1 ]
机构：
[1] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland
[2] Med Univ Bialystok, Fac Med, Bialystok, Poland
[3] Maria Sklodowska Curie Bialystok Oncol Ctr, Colorectal Canc Unit, Bialystok, Poland
来源：
CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2024年 / 10卷 / 04期
关键词：
liver diseases; cannabinoids; CB1; CB2; endocannabinoids; CB1; RECEPTORS; RISK-FACTOR; OBESITY; RIMONABANT; INFLAMMATION; DRONABINOL; ACTIVATION; EXPRESSION; MANAGEMENT; STEATOSIS;
D O I：
10.5114/ceh.2024.145358
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Cannabinoids are biologically active substances acting via feedback-coupled CB1 and CB2 receptors. Their expression in myofibroblasts and liver endothelial cells is reported to be elevated in chronic liver diseases. The effect of CB1 receptor stimulation is to increase fibrosis and inflammatory activity in the liver by stimulating stellate cells, while activation of the CB2 receptor results in inhibition of fibrosis. Stimulation of the CB1 receptor may also lead to progression of liver steatosis and carcinogenesis. In end-stage liver disease, the endocannabinoid system plays an important role in the pathogenesis of encephalopathy and vascular effects, such as portal hypertension, splanchnic vasodilatation and cirrhotic cardiomyopathy. It seems that interference in endocannabinoid transmission may serve as an attractive target for the development of hepatological drugs.
引用
收藏
页码：211 / 217
页数：7
相关论文
共 44 条
[1]   Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age [J].
Agudo, J. ;
Martin, M. ;
Roca, C. ;
Molas, M. ;
Bura, A. S. ;
Zimmer, A. ;
Bosch, F. ;
Maldonado, R. .
DIABETOLOGIA, 2010, 53 (12) :2629-2640
[2]   Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer [J].
Alderman, Bryony ;
Hui, David ;
Mukhopadhyay, Sandip ;
Bouleuc, Carole ;
Case, Amy A. ;
Amano, Koji ;
Crawford, Gregory B. ;
de Feo, Giulia ;
Sbrana, Andrea ;
Tanco, Kimberson ;
To, Josephine ;
Garsed, Jessica ;
Davis, Mellar .
SUPPORTIVE CARE IN CANCER, 2023, 31 (01)
[3]   Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back [J].
Almogi-Hazan, Osnat ;
Or, Reuven .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) :1-17
[4]   Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products [J].
An, Dongchen ;
Peigneur, Steve ;
Hendrickx, Louise Antonia ;
Tytgat, Jan .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) :1-33
[5]   Dronabinol in Severe, Enduring Anorexia Nervosa: A Randomized Controlled Trial [J].
Andries, Alin ;
Frystyk, Jan ;
Flyvbjerg, Allan ;
Stoving, Rene Klinkby .
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2014, 47 (01) :18-23
[6]   Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice [J].
Avraham, Y ;
Israeli, E ;
Gabbay, E ;
Okun, A ;
Zolotarev, O ;
Silberman, I ;
Ganzburg, V ;
Dagon, Y ;
Magen, I ;
Vorobia, L ;
Pappo, O ;
Mechoulam, R ;
Ilan, Y ;
Berry, EM .
NEUROBIOLOGY OF DISEASE, 2006, 21 (01) :237-245
[7]   Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS [J].
Badowski, Melissa E. ;
Perez, Sarah E. .
HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2016, 8 :37-45
[8]   Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis [J].
Bátkai, S ;
Járat, Z ;
Wagner, JA ;
Goparaju, SK ;
Varga, K ;
Liu, J ;
Wang, L ;
Mirshahi, F ;
Khanolkar, AD ;
Makriyannis, A ;
Urbaschek, R ;
Garcia, N ;
Sanyal, AJ ;
Kunos, G .
NATURE MEDICINE, 2001, 7 (07) :827-832
[9]   CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES [J].
BOUABOULA, M ;
RINALDI, M ;
CARAYON, P ;
CARILLON, C ;
DELPECH, B ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01) :173-180
[10]   Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes [J].
De Gottardi, Andrea ;
Spahr, Laurent ;
Ravier-Dall'Antonia, Florence ;
Hadengue, Antoine .
LIVER INTERNATIONAL, 2010, 30 (10) :1482-1489
12345